It is worth noting that the reduced frequency of PD-1-expressing lymphocytes might have favorable effects on avoiding tumor-induced PD-L1-driven suppression of the immune response which has been previously suggested to be responsible for the reduced survival of breast cancer patients [18]. This evidence concerns the gene PDCD1 and breast cancer.